D-0940-2023 Class II Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0940-2023 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Jul 13, 2023 and is designated Class II. Reason for recall: Presence of Foreign Substance: Metal embedded in a tablet. The recall status is terminated (terminated Feb 12, 2024). Affected quantity: 7313 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 2, 2023
Initiation Date
Jul 13, 2023
Termination Date
Feb 12, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7313 bottles

Product description

Methylphenidate Hydrochloride Tablets, USP 20mg, Rx Only, 100 Tablets per bottle, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries Inc., Cranbury, NJ 08512, NDC 57664-230-88.

Reason for recall

Presence of Foreign Substance: Metal embedded in a tablet.

Distribution pattern

Nationwide

Code information

Lot AC74459, Exp 07/31/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0940-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0940-2023. Report a data issue: hello@regdatalab.com.